A once-daily pill for ulcerative colitis has delivered strong results in a clinical trial, easing symptoms even in patients for whom other treatments had failed and raising hopes for a safer, more ...

Discover the best anti-inflammatory lifestyle changes including food swaps, movement and stress management to ease chronic inflammation ...

Adding just a few anti-inflammatory foods to your diet can offset the negative effects of inflammation and improve long-term health. The seven options above, ranging from mushrooms to tart cherries, ...

Amyotrophic lateral sclerosis may involve an autoimmune component — a finding that could reshape treatment strategies and lead to new tools for predicting disease course.

In a new study by a team of U.S. scientists, a group of inflammatory immune cells was found to mistakenly target the C9ORF72 protein in nerve cells in people with amyotrophic lateral sclerosis (ALS) — ...

We all know that asthma impacts breathing. What may be less known is that the disease, which restricts our airways due to inflammatory responses, can be caused throughout our lifetime by a variety of ...

The research, backed by the National Institutes of Health, could one day lead to new treatments for cancer and a range of inflammatory diseases.

Researchers provide insights on tuning immunometabolism to resolve inflammation and promote repair at the bone–biomaterial interface ...

As seasons change across India, many people experience flare-ups of respiratory, skin, joint, and gut issues linked to low-grade inflammation.

Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Induction Trial Results in Participants With and Without Prior Inadequate Response ...

The discovery of cells that prevent the immune system from hurting the body is paving the way for new treatments for autoimmune diseases and cancer.

A Wayne State University study published in the Oct. 3, 2025, issue of Nature Communications revealed that Zika virus exposure during pregnancy causes long-term, sex-specific changes to a baby's ...